(Total Views: 571)
Posted On: 01/30/2025 12:40:29 PM
Post# of 149969
Whatever ends up happening, it's still very curious timing that this glitch (if that's what it is) happened right around the middle of the month where we're supposed to start screening patients for CRC, receive results from our second MASH study, submit the Alzheimer's protocol, and get the LATCH protocol finished/submitted.
It's a little disappointing that Dr. J didn't capitalize on the price run up to drop a PR or communicate with us at all so far this month, but it feels more than ever like something is brewing.
The CRC trial was supposed to start screening patients this month, but the Clinical Trials website hasn't been updated since November. First MASH results were supposed to be presented at the conference but weren't. Second MASH results were supposed to be revealed but haven't been. Then we get this "glitch" which hasn't ever happened at any time I can recall in the 5 years I've been here. We also haven't heard a word from the company about Dr. ML being part of our team and then being named head of HIV drug development at BMGF.
We know we have over $20m in the bank right now so no, this does not seem like every other time. The past two years we haven't had this kind of breathing room financially. With all of that money and everything being so hush hush at the moment, something seems to be happening.
It's a little disappointing that Dr. J didn't capitalize on the price run up to drop a PR or communicate with us at all so far this month, but it feels more than ever like something is brewing.
The CRC trial was supposed to start screening patients this month, but the Clinical Trials website hasn't been updated since November. First MASH results were supposed to be presented at the conference but weren't. Second MASH results were supposed to be revealed but haven't been. Then we get this "glitch" which hasn't ever happened at any time I can recall in the 5 years I've been here. We also haven't heard a word from the company about Dr. ML being part of our team and then being named head of HIV drug development at BMGF.
We know we have over $20m in the bank right now so no, this does not seem like every other time. The past two years we haven't had this kind of breathing room financially. With all of that money and everything being so hush hush at the moment, something seems to be happening.
(19)
(0)
Scroll down for more posts ▼